European Journal of Neurology

Calendar
pp. v-v(1)

Instructions for Authors
pp. vi-vii(2)

Delay in diagnosis of neuralgic amyotrophy in patients initially evaluated by non-neurologists
pp. e18-e18(1)
Authors: Chisholm, K.; Scala, S.; Srinivasan, J.

Efficacy of combined hyperbaric oxygenation therapy in a case of pyogenic spondylodiscitis accompanied by an epidural and pelvic intramuscular gaseous abscess and encephalomeningitis
pp. e19-e20(2)
Authors: Omori, N.; Takeuchi, K.; Tanaka, T.; Narai, H.; Kitagawa, T.; Abe, K.; Manabe, Y.

Haematopoietic stem-cell transplant for adult cerebral adrenoleukodystrophy
pp. e21-e22(2)
Authors: Fitzpatrick, A. S.; Loughrey, C. M.; Johnston, P.; McKee, S.; Spence, W.; Flynn, P.; Jones, F. G. C.; Morrow, J. I.

Uniting Chinese across Asia: the LRRK2 Gly2385Arg risk variant
pp. 203-204(2)
Authors: Tan, E. K.; Schapira, A. H.

Pericranial injection of botulinum toxin type A (Dysport^®) for tension-type headache - A multicentre, double-blind, randomized, placebo-controlled study
pp. 205-213(9)
Authors: Straube, A.; Empl, M.; Ceballos-Baumann, A.; Tölle, T.; Stefenelli, U.; Pfaffenrath, V.

In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion
pp. 214-218(5)
Authors: Seifert, F.; Struffert, T.; Hildebrandt, M.; Blümcke, I.; Brück, W.; Staykov, D.; Huttner, H. B.; Hilz, M.-J.; Schwab, S.; Bardutzky, J.

Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer′s disease risk
pp. 219-222(4)
Authors: Mateo, I.; Llorca, J.; Infante, J.; Rodríguez-Rodríguez, E.; Berciano, J.; Combarros, O.

Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients
pp. 223-228(6)
Authors: Broccoletti, T.; Del Giudice, E.; Amorosi, S.; Russo, I.; Di Bonito, M.; Imperati, F.; Romano, A.; Pignata, C.

Pineal gland cyst evaluated by transcranial sonography
pp. 229-233(5)
Authors: Budisic, M.; Bosnjak, J.; Lovrencic-Huzjan, A.; Mikula, I.; Bedek, D.; Demarin, V.

Glutathione-S-transferase P1 polymorphism and risk for essential tremor
pp. 234-238(5)
Authors: Martínez, C.; García-Martín, E.; Alonso-Navarro, H.; Benito-León, J.; Puertas, I.; Rubio, L.; López-Alburquerque, T.; Agúndez, J. A. G.; Jiménez-Jiménez, F. J.

Depression and anxiety amongst multiple sclerosis patients
pp. 239-245(7)
Authors: Beiske, A. G.; Svensson, E.; Sandanger, I.; Czujko, B.; Pedersen, E. D.; Aarseth, J. H.; Myhr, K. M.

Clinical and laboratory-reconfirmed myasthenia gravis: a population-based study
pp. 246-252(7)
Authors: Ööpik, M.; Puksa, L.; Lüüs, S.-M.; Kaasik, A.-E.; Jakobsen, J.

The response to IV rt-PA in very old stroke patients
pp. 253-256(4)
Authors: Gómez-Choco, M.; Obach, V.; Urra, X.; Amaro, S.; Cervera, Á.; Vargas, M.; Chamorro, Á.

Should levodopa dose be reduced when switched to stalevo?
pp. 257-261(5)
Authors: Linazasoro, G.; Kulisevsky, J.; Hernández, B.

Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia?
pp. 262-267(6)
Authors: Lyros, E.; Messinis, L.; Papathanasopoulos, P.

Bimodal administration of entacapone in Parkinson's disease patients improves motor control
pp. 268-273(6)
Authors: Bet, L.; Bareggi, S. R.; Pacei, F.; Bondiolotti, G.; Meola, G.; Schapira, A. H. V

Headaches in a rheumatology clinic: when one pain leads to another
pp. 274-277(4)
Authors: Williams, L.; O'Connell, K.; Tubridy, N.

How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study
pp. 278-283(6)
Authors: Sun, Y.; Lai, M.-S.; Lu, C.-J.; Chen, R.-C.

Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale
pp. 284-288(5)
Authors: Pascual, A. M.; Boscá, I.; Coret, F.; Escutia, M.; Bernat, A.; Casanova, B.

Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients
pp. 289-294(6)
Authors: Shimomura, T.; Anan, F.; Umeno, Y.; Eshima, N.; Saikawa, T.; Yoshimatsu, H.; Fujiki, M.; Kobayashi, H.

Differential diagnosis of cerebral infarction using an algorithm combining atrial fibrillation and D-dimer level
pp. 295-300(6)
Authors: Dougu, N.; Takashima, S.; Sasahara, E.; Taguchi, Y.; Toyoda, S.; Hirai, T.; Nozawa, T.; Tanaka, K.; Inoue, H.

LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China
pp. 301-305(5)
Authors: An, X.-K.; Peng, R.; Li, T.; Burgunder, J.-M.; Wu, Y.; Chen, W.-J.; Zhang, J.-H.; Wang, Y.-C.; Xu, Y.-M.; Gou, Y.-R.; Yuan, G.-G.; Zhang, Z.-J.

Bilateral cerebral hemispheric infarction associated with sildenafil citrate (Viagra^®) use
pp. 306-308(3)
Authors: Kim, K.-K.; Kim, D. G.; Ku, Y. H.; Lee, Y. J.; Kim, W.-C.; Kim, O. J.; Kim, H. S.

Induction of systemic TNFα in Natalizumab-treated multiple sclerosis
pp. 309-312(4)
Authors: Khademi, M.; Stol, D.; Olsson, T.; Wallström, E.

Erratum
pp. 313-313(1)